Health and Healthcare
Pain Therapeutics Jumps Almost 8% on Higher Volume
Published:
From Volume Spike Investor
Shares of Pain Therapeutics (PTIE) gained almost 8% on Friday as volume spiked more than 5 times the 3-month average daily volume.
There were no news releases or other significant events that could be detected, except for an announcement Wednesday, December the 13th by the company regarding the initiation of a phase III clinical trial.
Pain Therapeutics engages in the research and development of drugs for use in pain management, primarily in the area of opioid painkillers in the United States.
The company is worth more than $400 million on the market, and holds more than $200 in cash with no debt as last reported by Yahoo!Finance.
Shares of Pain Therapeutics closed at $9.46, a little less than 20% away from its 52-week high of $11.80 reached back in February of 2006.
Pain Therapeutics is a BioHealth Investor Stock Pick, and has made VSI’s Watch List.
Retirement can be daunting, but it doesn’t need to be.
Imagine having an expert in your corner to help you with your financial goals. Someone to help you determine if you’re ahead, behind, or right on track. With SmartAsset, that’s not just a dream—it’s reality. This free tool connects you with pre-screened financial advisors who work in your best interests. It’s quick, it’s easy, so take the leap today and start planning smarter!
Don’t waste another minute; get started right here and help your retirement dreams become a retirement reality.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.